Abzena’s Post

View organization page for Abzena, graphic

23,029 followers

Pharmaceutical Technology recently spoke with our SVP of Science & Technology, Parviz A. Shamlou, about the potential impact that the Biosecure Act may have on the pharmaceutical industry, as well as the progress of continuous manufacturing in #biopharma. Parviz shares, “We appreciate that [the Biosecure Act] is an important act designed to protect the health of citizens of this country. And we know we must do everything we can to avoid any unintended, potentially harmful use of our services as highlighted in the act,” says Shamlou. “Abzena has put in place a robust contingency plan as well as a CMC strategy designed to mitigate any such risk to the supply chain and the development of the assets that our customers bring to us.” Click here to listen to the interview: https://lnkd.in/eAMc4fiP #CDMO #CRO #Drugdevelopment #Supplychain

  • No alternative text description for this image
Talus Gaymore

Biopharmaceutical Process Engineer | Downstream and Upstream PD Scientist | Quality Control Specialist

5mo

Congratulations Dr. Shamlou

Like
Reply

To view or add a comment, sign in

Explore topics